Grace Therapeutics Inc (GRCE)
3.08
-0.06
(-1.75%)
USD |
NASDAQ |
Nov 05, 16:00
3.08
0.00 (0.00%)
After-Hours: 20:00
Grace Therapeutics Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2021 | 0.115M |
| December 31, 2020 | 0.081M |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| November 30, 2016 | |
| August 31, 2016 | |
| May 31, 2016 | |
| February 29, 2016 | -0.0129M |
| Date | Value |
|---|---|
| November 30, 2015 | 0.0038M |
| August 31, 2015 | 0.0053M |
| May 31, 2015 | 0.0041M |
| February 28, 2015 | -0.0807M |
| November 30, 2014 | 0.0252M |
| August 31, 2014 | 0.0069M |
| May 31, 2014 | 0.0517M |
| February 28, 2014 | 0.1668M |
| November 30, 2013 | 0.0267M |
| August 31, 2013 | 0.2525M |
| May 31, 2013 | 0.0062M |
| February 28, 2013 | 0.0276M |
| November 30, 2012 | 0.4272M |
| August 31, 2012 | 0.239M |
| May 31, 2012 | 0.0133M |
| February 29, 2012 | -0.1018M |
| November 30, 2011 | |
| August 31, 2011 | |
| May 31, 2011 | 0.0849M |
| February 28, 2011 | 0.029M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.081M
Minimum
Dec 2020
0.115M
Maximum
Mar 2021
0.098M
Average
0.098M
Median
Revenue (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 57.19M |
| Edesa Biotech Inc | -- |
| Lexaria Bioscience Corp | 0.084M |
| Xenon Pharmaceuticals Inc | -- |
| ESSA Pharma Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.617M |
| Total Expenses (Quarterly) | 4.963M |
| EPS Diluted (Quarterly) | -0.24 |
| Enterprise Value | 12.38M |
| Earnings Yield | -46.25% |
| Normalized Earnings Yield | -161.92 |